+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Osteoarthritis Market and Competitive Landscape - 2020

  • ID: 5023427
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Osteoarthritis Market and Competitive Landscape - 2020, provides comprehensive insights into the Osteoarthritis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Osteoarthritis market size and drug sales. It also provides insights into Osteoarthritis epidemiology and late stage pipeline.

This research covers the following: Osteoarthritis treatment options, Osteoarthritis late stage clinical trials pipeline, Osteoarthritis prevalence by countries, Osteoarthritis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Osteoarthritis pipeline: Find out drugs in clinical trials for the treatment of Osteoarthritis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Osteoarthritis epidemiology: Find out the number of patients diagnosed (prevalence) with Osteoarthritis by countries
  • Osteoarthritis drugs: Identify key drugs marketed and prescribed for Osteoarthritis in the US, including trade name, molecule name, and company
  • Osteoarthritis drugs sales: Find out the sales value for Osteoarthritis drugs by countries
  • Osteoarthritis market valuations: Find out the market size for Osteoarthritis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Osteoarthritis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Osteoarthritis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Osteoarthritis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Osteoarthritis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Osteoarthritis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Osteoarthritis Treatment Options

2. Osteoarthritis Pipeline Insights
2.1. Osteoarthritis Phase 3 Clinical Trials
2.2. Osteoarthritis Phase 2 Clinical Trials
2.3. Osteoarthritis Phase 1 Clinical Trials

3. Osteoarthritis Epidemiology Analysis by Countries

4. Germany Osteoarthritis Market Insights
4.1. Marketed Drugs for Osteoarthritis in Germany
4.2. Germany Osteoarthritis Market Size & Forecast
4.3. Germany Osteoarthritis Drugs Sales Forecast
4.4. Germany Osteoarthritis Market Share Analysis

5. France Osteoarthritis Market Insights
5.1. Marketed Drugs for Osteoarthritis in France
5.2. France Osteoarthritis Market Size & Forecast
5.3. France Osteoarthritis Product Sales Forecast
5.4. France Osteoarthritis Market Share Analysis

6. Italy Osteoarthritis Market Insights
6.1. Marketed Drugs for Osteoarthritis in Italy
6.2. Italy Osteoarthritis Market Size & Forecast
6.3. Italy Osteoarthritis Product Sales Forecast
6.4. Italy Osteoarthritis Market Share Analysis

7. Spain Osteoarthritis Market Insights
7.1. Marketed Drugs for Osteoarthritis in Spain
7.2. Spain Osteoarthritis Market Size & Forecast
7.3. Spain Osteoarthritis Product Sales Forecast
7.4. Spain Osteoarthritis Market Share Analysis

8. UK Osteoarthritis Market Insights
8.1. Marketed Drugs for Osteoarthritis in UK
8.2. UK Osteoarthritis Market Size & Forecast
8.3. UK Osteoarthritis Product Sales Forecast
8.4. UK Osteoarthritis Market Share Analysis

9. Europe Osteoarthritis Market Insights
9.1. Europe Osteoarthritis Market Size & Forecast
9.2. Europe Osteoarthritis Product Sales Forecast
9.3. Europe Osteoarthritis Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Osteoarthritis Phase 3 Clinical Trials, Global, 2020
Table 2: Osteoarthritis Phase 2 Clinical Trials, Global, 2020
Table 3: Osteoarthritis Phase 1 Clinical Trials, Global, 2020
Table 4: Osteoarthritis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Osteoarthritis in Germany, 2019
Table 6: Germany Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 8: Germany Osteoarthritis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Osteoarthritis in France, 2019
Table 10: France Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 12: France Osteoarthritis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Osteoarthritis in Italy, 2019
Table 14: Italy Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 16: Italy Osteoarthritis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Osteoarthritis in Spain, 2019
Table 18: Spain Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 20: Spain Osteoarthritis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Osteoarthritis in UK, 2019
Table 22: UK Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 24: UK Osteoarthritis Market Events and Trends, 2016 - 2024
Table 25: Europe Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Osteoarthritis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Osteoarthritis Pipeline by Phase (%), Global, 2020
Figure 2: Osteoarthritis Prevalence by Countries, 2016 - 2024
Figure 3: Germany Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 4: Germany Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 5: Germany Osteoarthritis Market Share by Drugs (%), 2019
Figure 6: Germany Osteoarthritis Market - Future Market Share (%), 2024
Figure 7: France Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 8: France Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 9: France Osteoarthritis Market Share by Drugs (%), 2019
Figure 10: France Osteoarthritis Market - Future Market Share (%), 2024
Figure 11: Italy Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 12: Italy Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 13: Italy Osteoarthritis Market Share by Drugs (%), 2019
Figure 14: Italy Osteoarthritis Market - Future Market Share (%), 2024
Figure 15: Spain Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 16: Spain Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 17: Spain Osteoarthritis Market Share by Drugs (%), 2019
Figure 18: Spain Osteoarthritis Market - Future Market Share (%), 2024
Figure 19: UK Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 20: UK Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 21: UK Osteoarthritis Market Share by Drugs (%), 2019
Figure 22: UK Osteoarthritis Market - Future Market Share (%), 2024
Figure 23: Europe Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 24: Europe Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 25: Europe Osteoarthritis Market Share by Drugs (%), 2019
Figure 26: Europe Osteoarthritis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll